News
-
Kyowa Kirin Buys Into Gene Therapy With Orchard Therapeutics Acquisition
The Orchard Therapeutics acquisition comes as the biotech’s gene therapy for metachromatic leukodystrophy approaches a March 2024 FDA decision. The ex vivo gene therapy is already commercialized in Europe, marketed as Libmeldy.
-
Investors Share Perspectives on 2023 Deals and Offer a Look at Emerging Areas of Interest
Investment trends will be a big theme at the HLTH event at the Las Vegas Convention Center October 8-11. In the runup to the conference, investors from Bessemer Venture Partners, Cleveland Clinic Innovations, Third Culture Capital and Intuitive Ventures offered their takes on 2023 investments.
-
Jorie Healthcare CEO Shares Why Automation is Critical to Revenue Cycle Management
The revenue cycle management business is using AI tools to automate cumbersome tasks to help hospitals operate more efficiently. It’s beginning to attract the attention of major healthcare organizations.
-
Artificial Intelligence, BioPharma
Already Partnered With Nvidia, Iambic Adds $100M for AI Drug Discovery
Iambic Therapeutics brings together software engineers and drug-hunting scientists, all sharing the goal of using artificial intelligence to optimize properties of small molecule drugs. The startup will apply its Series B financing to a cancer drug pipeline that includes two candidates on track for the clinic in 2024.
-
MedCity Influencers, Health Tech
Emerging Behavioral Health Technology: Keeping it Human-Centric
While it’s easy to be consumed by the latest technology and the potential influence it could have, it’s important to remember the ultimate role these platforms should play when it comes to improved patient outcomes.
-
Providence Plans to Spin Out a New Patient Engagement Startup, Marking Its 4th Incubated Company
Providence announced that it will spin out its fourth digital health startup in the first quarter of next year. The company, called Praia Health, offers a platform designed to build stronger relationships with patients by personalizing their healthcare journeys and connecting them to relevant resources and services.
-
Decreased Volume Variability & Declining Labor Expenses Are Helping Hospitals’ Finances Bounce Back
Hospitals’ operating margins are still in a worse place than they were before the pandemic, but 2023 is ending as a much more stable year for hospital finance than 2022, according to a new report from Kaufman Hall. Because this year hasn’t had any large Covid-19 surges, hospitals have seen less variability in patient volumes. This has helped them allocate their resources more efficiently and decrease their reliance on expensive contract labor.
-
Health Tech, Pharmacy, Startups
Pharmacy Automation Startup Emerges From Stealth With 20+ Customers And $9M Raised
San Francisco-based Plenful emerged from stealth on Tuesday. The startup sells a workflow tool that automates manual and administrative workflows for pharmacy technicians. In addition to its launch out of stealth mode, the company also announced that it has closed a $9 million funding round led by Bessemer Venture Partners and signed contracts with more than 20 customers.
-
FDA Authorizes Novavax’s Covid-19 Vax, Set to Join Fall Rollout of Updated Shots
Novavax’s updated version of its Covid-19 vaccine is now FDA authorized for use in the U.S., joining the approved shots from Moderna and partners Pfizer and BioNTech. Novavax said its protein-based vaccine will be available in coming days.
-
7wireVentures Launches $217M Digital Health Fund
7wireVentures launched its largest fund to date on Tuesday — the closing of the $217 million digital health fund brings the Chicago-based firm’s assets under management to more than $500 million. Two-thirds of the new fund’s capital will be allocated to 7wireVentures’ existing portfolio companies for follow-up investments, and the remaining third will go toward Series B and Series C funding round for companies in which the firm hasn’t yet invested.
-
Navigating Healthcare’s Data Revolution: Priorities, Opportunities, and Challenges for Health Systems
Arcadia recently partnered with HIMSS Market Insights to survey executives, IT, technology, and clinical leaders. Here’s what we found.
-
Consumer / Employer, Health Tech
Solera Health Introduces New Platform To Reduce Point Solution Fatigue
Solera Health recently launched HALO, a platform that allows payers and employers to manage both Solera point solution partners and non-Solera point solutions in one place.
-
Eli Lilly Jumps Into Radiopharmaceuticals via $1.4B Point Biopharma Acquisition
Acquiring Point Biopharma gives Eli Lilly a pipeline of radiopharmaceuticals, including one for prostate cancer that could rival Novartis’s Pluvicto. The deal comes ahead of an expected Phase 3 data readout for that Point therapeutic candidate.
-
These 10 Trends Are Affecting The Healthcare Economy The Most
Healthcare-focused market research firm Trilliant Health published a report detailing the 10 most significant economic trends affecting U.S. healthcare stakeholders in 2023. Some of the main ideas covered in the report included Americans’ worsening physical and mental health, the industry’s shift away from traditional care pathways, and the way patients’ decision making is becoming increasingly driven by consumerism.
-
Where Do DTC Providers and Payers Stand When It Comes to Telehealth?
A new J.D. Power report found that CVS ranks highest for telehealth satisfaction among direct-to-consumer companies, while UnitedHealthcare ranks highest among payers.
-
Novartis Kidney Disease Drug Hits First Goal of Study; 2024 FDA Filing Planned
Novartis’s iptacopan met the first of two main goals in its pivotal study in immunoglobulin A nephropathy, and the pharma giant plans to seek accelerated FDA approval next year. The drug could challenge two available therapies for the rare kidney disorder.
-
Weight Loss Drugs Will Have Impact Far Beyond Just On Drugmakers
A new PitchBook report listed several predictions for digital health companies in regards to weight loss drugs, including the potential for new weight loss startups and possible challenges for existing nutrition companies.
-
How UNC Health Saved Over $5M On Annual Nurse Turnover Costs
UNC Health published a study showing that Laudio’s automation software saved the health system $5.4 million in annual nurse turnover costs. The startup’s technology automates administrative tasks for frontline nurse managers — such as patient rounding, schedule making, and quality and safety checks.
-
Invitae’s First of Its Kind Cancer Test Receives FDA Marketing Authorization
The FDA awarded marketing authorization for a new Invitae test that uses next-generation sequencing to assess multiple genes to identify variants indicating a person’s predisposition for certain cancers. The regulatory action creates a new regulatory classification making Invitae’s test the predicate device for future cancer tests.
-
MedCity Influencers, Artificial Intelligence
Health Equity Begins with Increasing Diversity in Clinical Research: AI Can Help
It’s critical that we address these examples of institutionalized bias and racism in how we approach clinical trials for drugs and devices. While it’s a daunting task, the path forward is surprisingly clear, and AI can be instrumental in the next step of overcoming unconscious biases inherent in clinical trial processes.
Promoted
Payer’s Place: Dawn Maroney
Dawn Maroney, President, Markets of Alignment Health and CEO of Alignment Health Plan, to discuss how they are using technology to provide better service and care to consumers.
Promoted
Applying Remote Patient Monitoring to Surgery Prep and Recovery, Oncology and Women’s Health
Join us to learn about the latest trends in remote monitoring and how to extend its benefits beyond chronic conditions to more patients – all while using fewer staff resources.
